These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 20584693)

  • 21. [Gene expression profiling of nasopharyngeal carcinoma cell line 5-8F-EGFP and the liver metastatic 5-8F-H3B-EGFP cells].
    HAN C; YANG JL; YAO KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):473-7. PubMed ID: 21421486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
    Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.
    Huang D; Wang W; Feng Z; Wang L; Chen Y; Xie C; Meng J; Tang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):616-23. PubMed ID: 21873785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
    Jiang N; Zhan F; Cao L; Yao K; Li G
    Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistance.
    Krumbach R; Schüler J; Hofmann M; Giesemann T; Fiebig HH; Beckers T
    Eur J Cancer; 2011 May; 47(8):1231-43. PubMed ID: 21273060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of Ca2+ current features of nasopharyngeal carcinoma cells with different metastatic potentiality to their moving abilities].
    Liu SJ; Tian DF; He YC; Zeng L; Huang C; Liu YQ
    Ai Zheng; 2007 May; 26(5):473-9. PubMed ID: 17672935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
    Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [CD44 regulates biological behavior and Ras signaling pathway in nasopharyngeal carcinoma stem cells].
    He L; Luo JJ; Zhou FL; Fan JY; Shi HJ; He YC; Jiang YL
    Zhonghua Zhong Liu Za Zhi; 2021 Feb; 43(2):180-187. PubMed ID: 33601482
    [No Abstract]   [Full Text] [Related]  

  • 31. Direct correlation between double K-RAS mutation and mucinous carcinoma. A case report.
    Pacini L; Bastianelli D; Ponti D; Rosa P; Petrozza V; Giannini G; Ragona G; Calogero A
    Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):e4-7. PubMed ID: 25675084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of Testin in nasopharyngeal squamous cancer with high ability of metastasis].
    Zhong Z; Yin SC
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 31(21):1676-1680. PubMed ID: 29798126
    [No Abstract]   [Full Text] [Related]  

  • 33. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry.
    Porter MJ; Field JK; Leung SF; Lo D; Lee JC; Spandidos DA; van Hasselt CA
    Acta Otolaryngol; 1994 Jan; 114(1):105-9. PubMed ID: 8128845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ras mutations are uncommon in nasopharyngeal carcinoma.
    Yung WC; Sham JS; Choy DT; Ng MH
    Eur J Cancer B Oral Oncol; 1995 Nov; 31B(6):399-400. PubMed ID: 8746272
    [No Abstract]   [Full Text] [Related]  

  • 35. Development of cetuximab-resistant human nasopharyngeal carcinoma cell lines and mechanisms of drug resistance.
    Zuo Q; Shi M; Li L; Chen J; Luo R
    Biomed Pharmacother; 2010 Oct; 64(8):550-8. PubMed ID: 20630698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of silencing H-ras gene by RNA interference on cetuximab-sensitivity of cetuximab-resistant human nasopharyngeal carcinoma cells].
    Zuo Q; Luo RC
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):574-8. PubMed ID: 22325215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
    Zuo Q; Shi M; Chen J; Liao W
    Biomed Pharmacother; 2011 Jun; 65(3):168-74. PubMed ID: 21602020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
    Zuo Q; Luo RC
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlation between ras gene and the resistance of nasopharyngeal carcinoma to cetuximab].
    Zuo Q; Luo RC
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1415-7. PubMed ID: 20584693
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.